Radon Symptoms: EPA Surgeon General Honest Answer
Radon symptoms is among the most-searched radon questions, and the honest answer is the most consequential one in public-health communication about indoor air. Despite the popular search term, radon exposure does not cause acute toxic symptoms in humans at residential exposure levels. There is no detectable sign, sensation, cough, headache, fatigue pattern, or respiratory irritation that an individual can feel or observe during radon exposure. The body has no sensory mechanism for radon. EPA and the U.S. Surgeon General document only one health effect: increased long-term lung cancer risk, manifesting 5 to 25 or more years after sustained elevated exposure. EPA and the Surgeon General estimate radon causes approximately 21,000 lung cancer deaths per year in the United States — the second leading cause of lung cancer after smoking, and the leading cause among never-smokers. Any respiratory symptom should be evaluated by a physician immediately and not attributed to recent radon exposure. This guide summarizes EPA, Surgeon General, CDC, and American Lung Association guidance current as of 2026 and is informational only.
The honest answer: radon has no acute symptoms
Radon is a colorless, odorless, tasteless radioactive noble gas formed from the natural decay of uranium and radium in soil and rock. As an inert noble gas, it does not react chemically with body tissues. When inhaled, radon gas itself is largely exhaled within seconds. The body has no chemoreceptors for radon, no inflammatory response to typical residential exposure, and no nerve endings that signal its presence. EPA’s Citizen’s Guide states explicitly that radon “cannot be seen, smelled, or tasted, but it may be a problem in your home.”
What causes harm is the radioactive decay products: polonium-218 and polonium-214 (the radon “daughters”). These daughters attach to dust particles and aerosols in indoor air, are inhaled, deposit on lung tissue, and emit alpha particles as they continue to decay. Alpha radiation damages cellular DNA at close range. Over years and decades of repeated exposure, this damage accumulates and raises lifetime lung cancer risk in a dose-response relationship.
The Surgeon General Health Advisory framing
The U.S. Surgeon General issued a Health Advisory on radon in 2005 stating: “Indoor radon is the second-leading cause of lung cancer in the United States and breathing it over prolonged periods can present a significant health risk to families all over the country.” The Advisory remains in effect. EPA’s Indoor Air Quality program operates under this framing, treating radon as a leading preventable cause of lung cancer that no homeowner can detect without testing.
The 21,000 deaths per year estimate is derived from population-level epidemiology. The National Research Council’s BEIR VI report (1999) and subsequent updates have calibrated the dose-response model used to convert measured radon exposure into excess lung cancer risk. Approximately 2,900 of those 21,000 deaths occur among never-smokers; the remaining are among current or former smokers, where radon and smoking interact synergistically. For never-smokers exposed to 4 pCi/L for 70 years, the excess lifetime lung cancer risk is approximately 7 in 1,000. For smokers at the same exposure, the excess risk rises to 62 in 1,000.
What “symptoms of radon” actually refers to
When people search “radon symptoms,” they typically mean one of three things. First, they may be asking whether radon causes any acute physical sensation — to which the answer is no. Second, they may be asking what symptoms the eventual lung cancer caused by radon presents with — to which the answer is the same as any lung cancer (persistent cough, blood in sputum, chest pain, weight loss, recurrent pneumonia), appearing 5 to 25 years after the exposure. Third, they may be asking whether their current respiratory symptoms could be radon-related — to which the answer is no for current symptoms, and the symptoms need medical workup independent of any radon testing plan.
This three-way clarification is the most useful frame. The search term itself conflates the three questions, leading to confusion. The American Lung Association at lung.org separates the questions explicitly in its consumer guidance.
Why current respiratory symptoms warrant a physician, not radon worry
If a homeowner is currently experiencing cough, shortness of breath, chest tightness, fatigue, sinus irritation, or any other respiratory or constitutional symptom, the path is to see a physician immediately for evaluation. Causes to rule in or out include: viral upper respiratory infection, bacterial pneumonia, asthma exacerbation, allergic rhinitis, COPD, cardiac issues (heart failure can present with shortness of breath), occupational chemical exposures, and (if indicated) early-stage cancer. The physician’s diagnostic workup is independent of any home radon testing plan.
A clean radon test does not rule out any of these other causes. An elevated radon test does not explain symptoms experienced today, because radon’s effect takes years to manifest. The two investigations run on different timelines and address different questions. Skipping the physician visit because “the radon test was clean” is a dangerous error. So is skipping the radon test because “I feel fine.”
How testing actually informs the radon question
Since symptoms do not signal radon, the only meaningful intervention is testing. EPA recommends every home below the third floor be tested for radon. Front Range testing data shows approximately 40 to 50 percent of homes above the 4 pCi/L action level, well above the U.S. national average of around 6 percent. Most Colorado counties along the I-25 corridor sit in EPA Zone 1, the highest radon-potential tier.
Short-term test kits (charcoal or electret) run $15 to $30 and require 48 hours to 7 days of exposure. Long-term test kits (alpha-track) run $25 to $40 and require 90 days. CDPHE-supported county programs have periodically distributed free kits to Front Range residents. Continuous monitors (Airthings View Plus, Corentium Pro) cost $200 to $400 and provide hourly readings. For broader testing context, see the radon testing pillar overview.
Mitigation: the actual symptom-prevention pathway
If a test returns 4 pCi/L or higher, EPA recommends mitigation. The standard residential mitigation system is sub-slab depressurization (SSD), which uses a sealed PVC vent pipe from beneath the foundation slab routed above the roofline, with an inline fan creating negative pressure beneath the slab. Soil gas is drawn into the pipe before it can enter the home. Front Range SSD installation runs $1,200 to $2,500 turnkey by an NRPP-certified mitigator, and post-installation testing typically shows 80 to 99 percent reduction in indoor levels.
Mitigation is the only intervention that affects future lung cancer risk from radon. It does not affect any current symptoms, which have other causes. Post-mitigation testing within 30 days of activation confirms the system is working. EPA also recommends re-testing in the second year and then every two to five years thereafter to catch fan failures or other system degradation. For context on related framings, the symptoms of radon poisoning guide walks through the related search terms and what they actually mean.
The Iowa Radon Lung Cancer Study and other epidemiology
The U.S. EPA’s risk model draws on multiple epidemiological studies of radon exposure and lung cancer. The Iowa Radon Lung Cancer Study (published in 2000) tracked lung cancer rates among Iowa women with extensive home-occupancy histories, finding a clear dose-response relationship between residential radon exposure and lung cancer risk. The North American pooled analysis (2005) combined data from seven North American case-control studies and confirmed the dose-response, with statistically significant excess risk beginning around 2 to 4 pCi/L of long-term average exposure. The European pooled analysis (2005) reached similar conclusions across thirteen European studies.
These studies collectively establish that residential radon exposure is a real cause of lung cancer at the levels found in many homes, not just at the high occupational exposures originally documented in uranium miners. The risk model used by EPA, the National Research Council BEIR VI report, and the World Health Organization are all calibrated against these epidemiological data. None of the studies identifies acute symptoms; all identify only long-term cancer risk. The medical evidence base is consistent across decades and continents.
How radon risk compares to other common risks
To contextualize the 21,000 lung cancer deaths per year EPA attributes to radon, comparison with other common environmental and lifestyle risks helps. Smoking causes approximately 480,000 deaths per year in the U.S., dwarfing radon. Indoor air pollutants other than radon (cooking emissions, combustion products, household chemicals) collectively cause an estimated 10,000 to 20,000 lung-related deaths annually. Drunk driving causes approximately 10,000 traffic deaths per year. Radon sits in the same magnitude as drunk driving as a single-cause preventable mortality, which is why public-health authorities promote testing and mitigation as a standard household practice.
For never-smokers specifically, radon is the leading cause of lung cancer in the United States. The 2,900 never-smoker deaths attributed to radon exceed any other single environmental exposure for that population. This is part of why testing is recommended universally rather than only for high-risk individuals; the never-smoker population that develops radon-attributable lung cancer is statistically small but the cancers are largely preventable through mitigation.
Why this framing is repeated across radon resources
Every authoritative radon resource — EPA, Surgeon General, CDC, American Lung Association, National Cancer Institute, World Health Organization — repeats some version of the same framing: radon has no acute symptoms; the only health effect is long-term lung cancer risk; testing is the only way to know; mitigation is effective when needed. The repetition exists because the alternative framing (radon as a symptom-causing toxin) is both incorrect and dangerous. It misleads worried homeowners into delaying medical evaluation of current symptoms, and it implies that the absence of symptoms means radon is not a concern.
Front Range homeowners specifically should treat radon testing as routine, similar to checking smoke detectors or scheduling an HVAC inspection. The cost is low, the test is easy, and the geological prevalence in the region makes it disproportionately useful here.
How to talk to a physician about radon worry
Patients who have recently learned of high radon levels in their home sometimes raise the topic with their primary-care physician. The productive framing for these conversations is to communicate the specific test result (such as “our home tested at 8.5 pCi/L over a 90-day test”), the duration of occupancy at that level if known, and any concurrent risk factors (current or former smoking, family history of lung cancer, occupational exposures). The physician can then assess whether any additional baseline monitoring is appropriate.
For most patients with moderate radon exposure histories (4 to 10 pCi/L for some years) and no concerning symptoms, the physician typically recommends standard annual physical exams, lifestyle modifications such as smoking cessation if applicable, and prompt evaluation of any future respiratory symptoms. There is no specific medical test for radon exposure itself, and no standard preventive treatment exists for past exposure. The home-side action (mitigation) is the meaningful intervention; the medical-side action is routine monitoring for any cancer presentation that might develop years later.
What public-health agencies recommend
Public-health recommendations on radon are consistent across CDPHE, the U.S. Department of Health and Human Services, the National Cancer Institute, and the World Health Organization. The core recommendations are: test every home below the third floor regardless of perceived risk; if levels are at or above 4 pCi/L, mitigate; re-test after mitigation to confirm effectiveness; re-test every two to five years thereafter to catch system failures; for new construction in EPA Zone 1, install passive radon-resistant features that can be activated if testing shows elevated levels.
For Front Range communities, the recommendation is particularly emphatic because of the regional prevalence. CDPHE’s radon program at cdphe.colorado.gov maintains current testing recommendations and lists certified mitigators by county. Some counties offer free or subsidized test kits to residents through public-health partnerships. The Colorado Association of Realtors has endorsed radon awareness during real estate transactions, supporting the buyer’s right to test during inspection contingency.
References
- EPA Citizen’s Guide to Radon and Surgeon General Health Advisory — U.S. Environmental Protection Agency
- American Lung Association radon and lung cancer information — American Lung Association
- CDC radon and lung cancer guidance — Centers for Disease Control and Prevention
- NIH National Cancer Institute radon and lung cancer overview — National Institutes of Health
Front Range homeowners ready to test for radon and connect with a vetted NRPP-certified mitigator can reach out through our contact page.